BACKGROUND: African swine fever virus (ASFV) is the unique member of the Asfarviridae family and Asfivirus genus. It is an enveloped double-stranded DNA arbovirus that replicates in the cell cytoplasm, similar to poxviruses. There is no vaccine and no treatment available to control this virus. METHODS: We describe the use of small interfering RNA (siRNA) targeting the A151R and VP72 (B646L) genes to control the ASFV replication in vitro. RESULTS: Results suggest that siRNA targeting the A151R and VP72 genes can reduce both the virus replication and its levels of messenger RNA transcripts. The reduction was up to 4 log(10) copies on the virus titre and up to 3 log(10) copies on virus RNA transcripts levels. The combination of multiple siRNA did not improve the antiviral effect significantly, compared with use of individual siRNAs. CONCLUSIONS: The function of the A151R gene product in the virus replication cycle is yet unclear, but is essential. We also demonstrate that it is possible to inhibit, using small interfering RNA, a virus that replicates exclusively in the cell cytoplasm in specific viral factories.
BACKGROUND:African swine fever virus (ASFV) is the unique member of the Asfarviridae family and Asfivirus genus. It is an enveloped double-stranded DNA arbovirus that replicates in the cell cytoplasm, similar to poxviruses. There is no vaccine and no treatment available to control this virus. METHODS: We describe the use of small interfering RNA (siRNA) targeting the A151R and VP72 (B646L) genes to control the ASFV replication in vitro. RESULTS: Results suggest that siRNA targeting the A151R and VP72 genes can reduce both the virus replication and its levels of messenger RNA transcripts. The reduction was up to 4 log(10) copies on the virus titre and up to 3 log(10) copies on virus RNA transcripts levels. The combination of multiple siRNA did not improve the antiviral effect significantly, compared with use of individual siRNAs. CONCLUSIONS: The function of the A151R gene product in the virus replication cycle is yet unclear, but is essential. We also demonstrate that it is possible to inhibit, using small interfering RNA, a virus that replicates exclusively in the cell cytoplasm in specific viral factories.
Authors: Irene Rodríguez; Modesto Redrejo-Rodríguez; Javier M Rodríguez; Alí Alejo; José Salas; María L Salas Journal: J Virol Date: 2006-04 Impact factor: 5.103
Authors: L Zsak; M V Borca; G R Risatti; A Zsak; R A French; Z Lu; G F Kutish; J G Neilan; J D Callahan; W M Nelson; D L Rock Journal: J Clin Microbiol Date: 2005-01 Impact factor: 5.948
Authors: Shehnaz Lokhandwala; Suryakant D Waghela; Jocelyn Bray; Neha Sangewar; Chloe Charendoff; Cameron L Martin; Wisam S Hassan; Tsvetoslav Koynarski; Lindsay Gabbert; Thomas G Burrage; David Brake; John Neilan; Waithaka Mwangi Journal: PLoS One Date: 2017-05-08 Impact factor: 3.240
Authors: Alexandra Hübner; Bjoern Petersen; Günther M Keil; Heiner Niemann; Thomas C Mettenleiter; Walter Fuchs Journal: Sci Rep Date: 2018-01-23 Impact factor: 4.379
Authors: Elizabeth Ramirez-Medina; Elizabeth Vuono; Sarah Pruitt; Ayushi Rai; Nallely Espinoza; Alyssa Valladares; Edward Spinard; Ediane Silva; Lauro Velazquez-Salinas; Douglas P Gladue; Manuel V Borca Journal: Viruses Date: 2022-08-21 Impact factor: 5.818